LANP mediates neuritic pathology in Spinocerebellar ataxia type 1

被引:19
|
作者
Cvetanovic, Marija [1 ]
Kular, Rupinder K. [1 ]
Opal, Puneet [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
LANP; pp32; ANP32-A; Spinocerebellar ataxia type 1; SCA1; Neurite outgrowth; CREB-BINDING PROTEIN; SCA1 TRANSGENIC MICE; HUNTINGTONS-DISEASE; REPRESSES TRANSCRIPTION; HISTONE ACETYLATION; GROWTH-FACTOR; CAG REPEAT; TRINUCLEOTIDE REPEAT; GENE-PRODUCT; MOUSE MODEL;
D O I
10.1016/j.nbd.2012.07.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disease that results from a pathogenic glutamine-repeat expansion in the protein ataxin-1 (ATXN1). Although the functions of ATXN1 are still largely unknown, there is evidence to suggest that ATXN1 plays a role in regulating gene expression, the earliest process known to go awry in SCA1 mouse models. In this study, we show that ATXN1 reduces histone acetylation, a post-translational modification of histones associated with enhanced transcription, and represses histone acetyl transferase-mediated transcription. In addition, we find that depleting the Leucine-rich Acidic Nuclear Protein (LANP)-an ATXN1 binding inhibitor of histone acetylation-reverses aspects of SCA1 neuritic pathology. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 50 条
  • [41] Neuro-respiratory pathology in spinocerebellar ataxia
    Biswas, Debolina D.
    El Haddad, Lea
    Sethi, Ronit
    Huston, Meredith L.
    Lai, Elias
    Abdelbarr, Mariam M.
    Mhandire, Doreen Z.
    ElMallah, Mai K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 443
  • [42] Progress in pathogenesis studies of spinocerebellar ataxia type 1
    Cummings, CJ
    Orr, HT
    Zoghbi, HY
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 1079 - 1081
  • [43] Spinocerebellar ataxia type 1 and familial spontaneous pneumothorax
    Fukazawa, T
    Sasaki, H
    Kikuchi, S
    Hamada, K
    Hamada, T
    Tashiro, K
    NEUROLOGY, 1997, 49 (05) : 1460 - 1462
  • [44] Spinocerebellar ataxia type 20
    Elsdon Storey
    Melanie A. Knight
    Susan M. Forrest
    R. J. Mckinlay Gardner
    The Cerebellum, 2005, 4 : 55 - 57
  • [45] Combinatorial Gene Therapy for Spinocerebellar Ataxia Type 1
    Keiser, Megan S.
    Carrell, Ellie M.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2019, 27 (04) : 33 - 34
  • [46] Excessive daytime somnolence in spinocerebellar ataxia type 1
    Dang, Dien
    Cunnington, David
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 290 (1-2) : 146 - 147
  • [47] Dysregulation of alternative splicing in spinocerebellar ataxia type 1
    Olmos, Victor
    Thompson, Evrett N.
    Gogia, Neha
    Luttik, Kimberly
    Veeranki, Vaishnavi
    Ni, Luhan
    Sim, Serena
    Chen, Kelly
    Krause, Diane S.
    Lim, Janghoo
    HUMAN MOLECULAR GENETICS, 2024, 33 (02) : 138 - 149
  • [48] Spinal Cord Damage in Spinocerebellar Ataxia Type 1
    Carlos Roberto Martins
    Alberto Rolim Muro Martinez
    Thiago Junqueira Ribeiro de Rezende
    Lucas Melo Teixeira Branco
    José Luiz Pedroso
    Orlando G. P. Barsottini
    Iscia Lopes-Cendes
    Marcondes C. França
    The Cerebellum, 2017, 16 : 792 - 796
  • [49] Presymptomatic DNA diagnosis of spinocerebellar ataxia type 1
    Illarioshkin, SN
    IvanovaSmolenskaya, IA
    Limborskaya, SA
    Ovchinnikov, IV
    Markova, ED
    Slominskii, PA
    Klyushnikov, SA
    Miklina, NI
    GENETIKA, 1997, 33 (05): : 693 - 698
  • [50] Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
    Anne Sophie Grosch
    Jan Leo Rinnenthal
    Maria Rönnefarth
    Silke Lux
    Michael Scheel
    Matthias Endres
    Alexander U. Brandt
    Friedemann Paul
    Tanja Schmitz-Hübsch
    Martina Minnerop
    Sarah Doss
    The Cerebellum, 2021, 20 : 169 - 178